Gainers
- Bone Biologics (NASDAQ:BBLG) stock moved upwards by 17.7% to $1.07 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6 million.
- Definium Therapeutics (NASDAQ:DFTX) stock increased by 17.69% to $48.15. The market value of their outstanding shares is at $5.4 billion. The company's, Q2 earnings came out 4 days ago.
- Dermata Therapeutics (NASDAQ:DRMA) stock increased by 17.59% to $1.27. The company's market cap stands at $4.3 million. As per the press release, Q2 earnings came out yesterday.
- Apyx Medical (NASDAQ:APYX) shares moved upwards by 14.27% to $3.45. The company's market cap stands at $127.2 million. As per the press release, Q2 earnings came out 4 days ago.
- TransCode Therapeutics (NASDAQ:RNAZ) shares moved upwards by 13.7% to $3.9. The market value of their outstanding shares is at $3.6 million.
- Innate Pharma (NASDAQ:IPHA) shares rose 12.55% to $2.42. The market value of their outstanding shares is at $201.7 million.
Losers
- Silexion Therapeutics (NASDAQ:SLXN) stock decreased by 58.0% to $0.43 during Wednesday's pre-market session. The company's market cap stands at $1.1 million.
- Edap TMS (NASDAQ:FOCL) shares declined by 20.97% to $4.75. The market value of their outstanding shares is at $225.2 million.
- SILO Pharma (NASDAQ:SILO) stock fell 19.67% to $2.86. The market value of their outstanding shares is at $4.0 million.
- Concord Medical Services (NYSE:CCM) stock decreased by 15.06% to $4.4. The market value of their outstanding shares is at $22.4 million.
- Cryo-Cell International (AMEX:CCEL) shares declined by 14.53% to $3.0. The company's market cap stands at $28.2 million.
- Milestone Pharmaceuticals (NASDAQ:MIST) shares declined by 11.82% to $1.12. The company's market cap stands at $158.1 million. The company's, Q2 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment